1,295
Participants
Start Date
August 15, 2024
Primary Completion Date
December 31, 2028
Study Completion Date
December 31, 2030
Measurement of circulating tumor-DNA
Liquid biopsies will be collected at baseline and prospectively during follow-up to measure circulating tumor-DNA.
Collection of patient-reported outcomes
Patient-reported outcomes will be collected at baseline and prospectively during follow-up.
Algorithmically determined telephone interview with a nurse
Dependent on the patient's responses on the patient-reported outcome measures.
RECRUITING
Copenhagen University Hospital, Copenhagen
RECRUITING
Aarhus University Hospital, Aarhus N
Aarhus University Hospital
OTHER
Danish Cancer Society
OTHER
Danish Comprehensive Cancer Center
OTHER
Rigshospitalet, Denmark
OTHER
University of Aarhus
OTHER